Shanghai Pharmtech Co., Ltd
  HOME ABOUT US PRODUCTS OUTSOURCING SERVICE QA&RA CAREER CONTACT US  
 
  HIGHLIGHT
   
Closantel Carprofen
Ceftiofur Doramectin
Flumethrin Fipronil*
Fluazuron Dicyclanil
Meloxicam Milbemycin Oxime *
Moxidectin * Pirlimycin *
Praziquantel Selamectin *
Toltrazuril Triclabendazole

* products under patent protection and can only be supplied for R&D purpose under Bolar Provision
ABOUT US

Growing with the dynamic changing veterinary industry in China, Shanghai Pharmtech was founded as a comprehensive veterinary products producer and supplier by the investment of Sinopharm International in 2002. Based on state-of-art GMP manufacturing facilities and excellent technical support for both domestic and international customers, Shanghai Pharmtech aims to be one leading player in providing services in veterinary API & formulation developing, manufacturing, contract R&D and manufacturing (OEM), domestic & overseas registration, pre-clinical test and regulatory affairs support.

Besides focusing on developing veterinary generic APIs which patent just expired or will expire, Shanghai Pharmtech also started to develop the formulation for cattle, sheep, pig, poultry and companion animals through jointly working with international and domestic R&D organizations. Located in Shanghai Zhangjiang High-Tech Park, the Chinese famous drug valley, the significant advantages of R&D platform and facilities make us more convenient in contract development and manufacturing for customers.

Up to end of 2007, we have established business relationship and cooperation with many multinational companies and regional outstanding companies, most of which are famous in the animal health industry. Through our efforts and good management, Shanghai Pharmtech will be the professional and famous company dedicated in animal health field in the nearby future.
 
NEWS

• In May, 2008, commercial production of Dicyclanil & its EDMF compilation is process,which is estimated to be finished in the end of 2008.

• In earlier of June, we finished the lab synthesis of Penethamate Hydriodide

• A R&D lab for formulation development is established in Zhangjiang “Drug valley”

• Moscow, Russia, 27 May - 29 May 2008, VIV Europe, Booth No: 35J4

• Shanghai, China, 24 June - 26 June 2008, CPhI & ICSE China, Booth No: 2E22

• Rio de Janeiro, Brazil, 19 August - 21 August 2008, CPhI South America, Booth No: 415

• Messe Frankfurt, Germany, 30 September - 2 October 2008, CPhI Europe, Booth No: CP5018
Copyright(C)2008,Shanghai Pharmtech Co., Ltd. All Rights Reserved.
 Supported by ChemNet ChinaChemNet Toocle